Pivotal Study of N-acetyl-L-leucine for CACNA1A
NCT07221292
·
clinicaltrials.gov ↗
PHASE3
Phase
NOT_YET_RECRUITING
Status
60
Enrollment
INDUSTRY
Sponsor class
Conditions
CACNA1A
Spinocerebellar Ataxia Type 6
Episodic Ataxia Type 2
Familial Hemiplegic Migraine-1
Interventions
DRUG:
N-Acetyl-L-Leucine
OTHER:
Placebo
Sponsor
IntraBio Inc